indobufen has been researched along with thromboxane b2 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bonomi, E; Canevari, A; Grignani, G; Milanesi, G; Pacchiarini, L; Tacconi, F; Zucchella, M | 1 |
| Di Somma, M; Ferrario, R; Patrignani, P; Patrono, C; Romanzini, L; Volpi, D | 1 |
| Cerletti, C; Colombo, M; Manarini, S; Tavani, A | 1 |
| Bianchi, C; Ciabattoni, G; Coppola, E; Mariello, F; Natale, A; Rebuzzi, AG | 1 |
| Fabris, F; Gerunda, GE; Girolami, A; Luzzatto, G; Zangrandi, F | 1 |
| Colli, S; Lavezzari, M; Maderna, P; Mannucci, L; Sirtori, CR; Tremoli, E | 1 |
| Bevilacqua, C; Cattaneo, M; Lecchi, A; Mannucci, PM | 1 |
| Carriero, MR; Cerletti, C; de Gaetano, G; Mussoni, L | 1 |
| Celi, V; Chello, M; Colonna, A; Marchese, AR; Mastroroberto, P; Romano, F | 1 |
| Cipollone, F; Cuccurullo, F; Greco, A; Liuzzo, G; Maseri, A; Padovano, R; Panara, MR; Patrignani, P; Patrono, C; Quaranta, G; Rebuzzi, AG | 1 |
| Alessandrini, P; Bon, GB; Bucciarelli, T; Ciabattoni, G; Cipollone, F; Costantini, F; Davi, G; Mezzetti, A; Minotti, G; Patrono, C | 1 |
| Banfi, C; Barbieri, SS; Brambilla, M; Colli, S; Eligini, S; Saliola, M; Tremoli, E; Violi, F | 1 |
| Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Paravati, V; Pellicano, M; Pulcinelli, FM; Tanzilli, G; Torromeo, C | 1 |
| Choi, HI; Lee, JY; Sung, KC | 1 |
| Abdus, S; Bai, J; Eikelboom, JW; Gong, X; Gu, Q; Li, C; Lu, Y; Mei, L; Shi, L; Tan, C; Ullah, I; Wang, G; Yang, M; Ye, Z | 1 |
5 trial(s) available for indobufen and thromboxane b2
| Article | Year |
|---|---|
Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.
Topics: Adult; Aged; Blood Platelets; Female; Humans; Isoindoles; Male; Middle Aged; Myocardial Infarction; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2 | 1990 |
Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arterial Occlusive Diseases; Cyclooxygenase Inhibitors; Humans; Intermittent Claudication; Isoindoles; Lactic Acid; Middle Aged; Neutrophil Activation; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2 | 1996 |
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina.
Topics: Aged; Angina, Unstable; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Prostaglandin-Endoperoxide Synthases; Reference Values; Thromboxane A2; Thromboxane B2 | 1997 |
Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Percutaneous Coronary Intervention; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Thromboxane B2; Ticlopidine; Treatment Outcome | 2013 |
Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
Topics: Aged; Aspirin; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2021 |
10 other study(ies) available for indobufen and thromboxane b2
| Article | Year |
|---|---|
Thromboxane production by platelets during tumor cell-induced platelet activation.
Topics: Adult; Apyrase; Blood Platelets; Dose-Response Relationship, Drug; Hirudins; Humans; Iodoacetates; Iodoacetic Acid; Isoindoles; Neoplasms; Phenylbutyrates; Phenylmercury Compounds; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Radioimmunoassay; Thromboxane B2 | 1991 |
Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood.
Topics: Adult; Arachidonate 5-Lipoxygenase; Calcimycin; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; In Vitro Techniques; Isoindoles; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Stereoisomerism; Thromboxane B2 | 1990 |
The (+)-enantiomer is responsible for the antiplatelet and anti-inflammatory activity of (+/-)-indobufen.
Topics: Animals; Gastric Mucosa; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pleurisy; Rats; Rats, Inbred Strains; Stereoisomerism; Thromboxane B2 | 1990 |
Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.
Topics: Aged; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Humans; Isoindoles; Liver Cirrhosis; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Count; Platelet Factor 4; Thrombocytopenia; Thromboxane B2 | 1987 |
Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk.
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation; Dose-Response Relationship, Drug; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Thromboxane B2 | 1987 |
In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Female; Humans; Isoindoles; Male; Phenylbutyrates; Platelet Aggregation; Thromboxane B2 | 1987 |
Low dose aspirin does not prevent fibrinolytic response to venous occlusion.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Aspirin; Fibrinolysis; Hematocrit; Humans; Isoindoles; Phenylbutyrates; Thrombosis; Thromboxane B2 | 1986 |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Humans; Hypercholesterolemia; Isoindoles; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Phenylbutyrates; Platelet Activation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thromboxane B2; Vitamin E | 1997 |
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.
Topics: Cells, Cultured; Cyclooxygenase Inhibitors; Depression, Chemical; Dinoprostone; Flow Cytometry; Humans; Isoindoles; Lipopolysaccharides; Monocytes; Phenylbutyrates; Thromboplastin; Thromboxane A2; Thromboxane B2; Thromboxanes | 2006 |
Comparison of aspirin and indobufen in healthy volunteers.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Cross-Over Studies; Drug Administration Schedule; Female; Healthy Volunteers; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin-Endoperoxide Synthases; Thromboxane B2 | 2016 |